Clinical Trials Browser

Phase 1/2 × Completed × Advanced/Metastatic Solid Tumors × Clear all

NCT04645069 2024-08-14

ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors